Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor
Nataliya Prokhnevska, Maria A. Cardenas, Rajesh M. Valanparambil, et al.
Immunity (2022) Vol. 56, Iss. 1, pp. 107-124.e5
Open Access | Times Cited: 190

Showing 1-25 of 190 citing articles:

The cancer-immunity cycle: Indication, genotype, and immunotype
Ira Mellman, Daniel S. Chen, Thomas Powles, et al.
Immunity (2023) Vol. 56, Iss. 10, pp. 2188-2205
Open Access | Times Cited: 351
Intratumoral dendritic cell–CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma
Assaf Magen, Pauline Hamon, Nathalie Fiaschi, et al.
Nature Medicine (2023) Vol. 29, Iss. 6, pp. 1389-1399
Closed Access | Times Cited: 184
Emerging evidence for adapting radiotherapy to immunotherapy
Lorenzo Galluzzi, Molykutty J. Aryankalayil, C. Norman Coleman, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 8, pp. 543-557
Closed Access | Times Cited: 169
CD8+ T cells in the cancer-immunity cycle
Josephine R. Giles, Anna-Maria Globig, Susan M. Kaech, et al.
Immunity (2023) Vol. 56, Iss. 10, pp. 2231-2253
Open Access | Times Cited: 161
Tertiary lymphoid structures and B cells: An intratumoral immunity cycle
Wolf H. Fridman, Maxime Meylan, Guilhem Pupier, et al.
Immunity (2023) Vol. 56, Iss. 10, pp. 2254-2269
Open Access | Times Cited: 116
Dendritic cells as shepherds of T cell immunity in cancer
Mikaël J. Pittet, Mauro Di Pilato, Christopher Garris, et al.
Immunity (2023) Vol. 56, Iss. 10, pp. 2218-2230
Open Access | Times Cited: 92
Challenges in developing personalized neoantigen cancer vaccines
Peter D. Katsikis, Ken J. Ishii, Christopher Schliehe
Nature reviews. Immunology (2023) Vol. 24, Iss. 3, pp. 213-227
Closed Access | Times Cited: 91
A distinct stimulatory cDC1 subpopulation amplifies CD8+ T cell responses in tumors for protective anti-cancer immunity
Philippa Meiser, Moritz Knolle, Anna Hirschberger, et al.
Cancer Cell (2023) Vol. 41, Iss. 8, pp. 1498-1515.e10
Open Access | Times Cited: 86
Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responses
Felix Bayerl, Philippa Meiser, Sainitin Donakonda, et al.
Immunity (2023) Vol. 56, Iss. 6, pp. 1341-1358.e11
Open Access | Times Cited: 80
Targeting innate immune pathways for cancer immunotherapy
Longyue L. Cao, Jonathan C. Kagan
Immunity (2023) Vol. 56, Iss. 10, pp. 2206-2217
Open Access | Times Cited: 78
Stem-like exhausted and memory CD8+ T cells in cancer
Thomas Gebhardt, Simone L. Park, Ian A. Parish
Nature reviews. Cancer (2023) Vol. 23, Iss. 11, pp. 780-798
Closed Access | Times Cited: 70
Human lung cancer harbors spatially organized stem-immunity hubs associated with response to immunotherapy
Jonathan H. Chen, Linda T. Nieman, Maxwell Spurrell, et al.
Nature Immunology (2024) Vol. 25, Iss. 4, pp. 644-658
Open Access | Times Cited: 51
Bispecific dendritic-T cell engager potentiates anti-tumor immunity
Y Itai, Oren Barboy, Ran Salomon, et al.
Cell (2024) Vol. 187, Iss. 2, pp. 375-389.e18
Open Access | Times Cited: 44
PGE2 limits effector expansion of tumour-infiltrating stem-like CD8+ T cells
Sebastian Lacher, Janina Dörr, Gustavo Pereira de Almeida, et al.
Nature (2024) Vol. 629, Iss. 8011, pp. 417-425
Open Access | Times Cited: 44
CD4+ T cell activation distinguishes response to anti-PD-L1+anti-CTLA4 therapy from anti-PD-L1 monotherapy
Amelie Franken, Michel Bila, Aurelie Mechels, et al.
Immunity (2024) Vol. 57, Iss. 3, pp. 541-558.e7
Open Access | Times Cited: 33
The B7:CD28 family and friends: Unraveling coinhibitory interactions
Kelly P. Burke, Apoorvi Chaudhri, Gordon J. Freeman, et al.
Immunity (2024) Vol. 57, Iss. 2, pp. 223-244
Open Access | Times Cited: 32
LAG-3 sustains TOX expression and regulates the CD94/NKG2-Qa-1b axis to govern exhausted CD8 T cell NK receptor expression and cytotoxicity
Shin Foong Ngiow, Sasikanth Manne, Yinghui Huang, et al.
Cell (2024) Vol. 187, Iss. 16, pp. 4336-4354.e19
Closed Access | Times Cited: 25
Immunomodulatory effects and improved outcomes with cisplatin- versus carboplatin-based chemotherapy plus atezolizumab in urothelial cancer
Matthew D. Galsky, Xiangnan Guan, Deepali Rishipathak, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101393-101393
Open Access | Times Cited: 24
Spatiotemporal single-cell analysis decodes cellular dynamics underlying different responses to immunotherapy in colorectal cancer
Yuqing Chen, Dongfang Wang, Yingjie Li, et al.
Cancer Cell (2024) Vol. 42, Iss. 7, pp. 1268-1285.e7
Open Access | Times Cited: 22
Regulation and impact of tumor-specific CD4+ T cells in cancer and immunotherapy
Mengdi Guo, M. Liu, David G. Brooks
Trends in Immunology (2024) Vol. 45, Iss. 4, pp. 303-313
Closed Access | Times Cited: 20
The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity
Patricia Ho, Johannes C. Melms, Meri Rogava, et al.
Cancer Cell (2023) Vol. 41, Iss. 7, pp. 1207-1221.e12
Open Access | Times Cited: 37
Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trial
Manuel Rodrigues, Giulia Vanoni, Pierre Loap, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 34
Chronic antigen in solid tumors drives a distinct program of T cell residence
Noah Veis Gavil, Milcah C. Scott, Eyob Weyu, et al.
Science Immunology (2023) Vol. 8, Iss. 84
Open Access | Times Cited: 29
Cellular and molecular waypoints along the path of T cell exhaustion
Xin Lan, Caitlin C. Zebley, Ben Youngblood
Science Immunology (2023) Vol. 8, Iss. 87
Open Access | Times Cited: 26
Characteristics and anatomic location of PD-1 + TCF1 + stem-like CD8 T cells in chronic viral infection and cancer
Se Jin Im, Rebecca C. Obeng, Tahseen H. Nasti, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 41
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top